Full Press Release Details
FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab).
REGN
FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)
Key Takeaway: FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)